W.P. Steward

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Armando Santoro, T Türsz, Henning T. Mouridsen et al. · Journal of Clinical Oncology · 1995 · 526 citations

Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.

N C Levitt, Ferry A.L.M. Eskens, Kenneth J. O’Byrne et al. · PubMed · 2001 · 136 citations

Tumor Response, Chemoprevention Strategy, Pharmacological Study +14

Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow

M Freshney, Lindsay McNair, Anne Parker et al. · Blood · 1996 · 85 citations

Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.

W.P. Steward, Dunlop Dj, G Dabouis et al. · PubMed · 1996 · 58 citations

Latest trends in cancer incidence among UK South Asians in Leicester

Lucy Smith, J. L. Botha, A. Benghiat et al. · British Journal of Cancer · 2003 · 52 citations · Full text

Epidemiology Of Cancer, Cancer Incidence, Cancer Registration +17